ClinConnect ClinConnect Logo
Search / Trial NCT07139678

Safe Use of Mobility Aids Checklist (SUMAC) for 4-wheeled Walker Use in Turkish Geriatric Population

Launched by ANKARA YILDIRIM BEYAZIT UNIVERSITY · Aug 18, 2025

Trial Information

Current as of September 07, 2025

Not yet recruiting

Keywords

Dependent Ambulation Dementia

ClinConnect Summary

This clinical trial is looking at a tool called the Safe Use of Mobility Aids Checklist (SUMAC) to see if it works well for older adults in Turkey who have dementia and use a 4-wheeled walker. The researchers want to find out if SUMAC is a reliable and accurate way to check how safely these walkers are being used. This is important because using a walker safely can help prevent falls and keep people more independent.

To take part, individuals need to be 65 years or older, have a dementia diagnosis, use a 4-wheeled walker, and be able to understand and speak Turkish. They also need to have a certain level of thinking ability, measured by a short test called the Mini Mental State Examination (MMSE), and be able to walk without help from another person. Participants will be asked to fill out some questionnaires and perform tasks from the SUMAC to see how well the checklist works. People with serious walking problems, balance issues, severe vision or hearing loss, serious heart problems, recent surgeries, or cancer treatment will not be eligible. This study is not yet recruiting participants but aims to make walker use safer for older adults with dementia in Turkey.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Having a diagnosed dementia
  • Using 4-wheeled walker
  • Being 65 years old or older
  • Being able to understand and speak Turkish
  • Having graduated from at least middle school
  • Being able to follow the instructions and act accordingly
  • Being able to walk without another person's help
  • Having gotten 18-23 points from the The Mini Mental State Examination (MMSE)
  • Exclusion Criteria:
  • Having mobility limitations due to musculoskeletal and neurological problems
  • Having problems walking due to neurological diseases such as Parkinson, cerebrovascular diseases and so on
  • Having balance problems due to vestibular conditions
  • Having severe visual impairment and/or severe hearing loss
  • Having unstable cardiovascular diseases
  • Having malignancy and/or receiving treatment for malignancy
  • Having had a surgery related to neurological and/or orthopedic problems in the past 6 months
  • Not being willing to participate

About Ankara Yildirim Beyazıt University

Ankara Yıldırım Beyazıt University is a leading academic institution in Turkey, renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, the university leverages its expertise in healthcare and innovative research methodologies to conduct ethical and scientifically rigorous clinical studies. By fostering collaboration among multidisciplinary teams, Ankara Yıldırım Beyazıt University aims to contribute to the development of novel therapies and enhance patient care, while adhering to the highest standards of regulatory compliance and patient safety.

Locations

Patients applied

0 patients applied

Trial Officials

Betül Kaya, RA

Study Director

Ankara Yildirim Beyazıt University

Bahar Anaforoğlu, Prof.

Principal Investigator

Ankara Yildirim Beyazıt University

Nezehat Ö Ünlüer, Assoc. Prof.

Study Director

Sağlık Bilimleri University

Yasemin Ateş Sarı, Dr.

Study Director

Ankara Yildirim Beyazıt University

Büşra Kalkan Balak, TA

Study Director

Yüksek İhtisas University

Sevilay S Baş, Dr.

Study Director

Ankara Yildirim Beyazıt University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported